Physician profile
Calli Vanlangendonck
NPI 1205408275
$856.84
in general payments reported to CMS, 2019-2025
15 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $452 · 2023: $73.36 · 2024: $201 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $226.65 | 2022 | |
| Alexion Pharmaceuticals, INC. | $116.63 | 2022 | |
| Calliditas Therapeutics US INC. | $108.53 | 2022 | |
| Sumitomo Pharma America, INC. | $84.49 | 2023-2025 | Gemtesa |
| Urogen Pharma, INC. | $58.89 | 2024-2025 | |
| Boston Scientific Corporation | $41.88 | 2023 | Ams 700 |
| Abc Home Medical Supply, INC. | $34.79 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $31.53 | 2024 | Andexxa |
| Progenics Pharmaceuticals, INC. | $28.36 | 2024 | |
| Teleflex LLC | $27.88 | 2024 | |
| Janssen Biotech, INC. | $27.60 | 2025 | Erleada |
| Merck Sharp & Dohme LLC | $23.03 | 2024 | Keytruda |
| Hollister Incorporated | $17.14 | 2024 | |
| Janssen Pharmaceuticals, INC | $15.99 | 2024 | Xarelto |
| Gilead Sciences, INC. | $13.45 | 2024 | Veklury |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Calli Vanlangendonck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.